Nonetheless, to our knowledge, no prior work has examined how FGFR3 alterations functionally affect the tumor microenvironment, nor how acute FGFR inhibition may cooperate with ICI in FGFR3-altered bladder cancer. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.